What is NDC 70710-1937?

70710-1937 is the product NDC for Verapamil Hydrochloride, Verapamil hydrochloride 2.5 mg/mL injection, solution, listed with the FDA by Zydus Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Zydus Pharmaceuticals USA Inc., NDC labeler code 70710. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Verapamil Hydrochloride?

131 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Verapamil Hydrochloride NDC 70710-1937

NDC codes

FDA NDC Directory

Product NDC (as listed)70710-1937Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70710-1937Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70710-1937-7	7071019370770710193707	25 CARTON in 1 CARTON (70710-1937-7) / 5 VIAL in 1 CARTON (70710-1937-5) / 2 mL in 1 VIAL (70710-1937-1)Marketed from Oct 17, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Verapamil Hydrochloride
Generic name (nonproprietary): verapamil hydrochloride
Active ingredients: Verapamil hydrochloride — 2.5 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Zydus Pharmaceuticals USA Inc.NDC labeler code 70710
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214215
Marketing start: Oct 17, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Calcium Channel Antagonists (Mechanism)Cytochrome P450 3A Inhibitors (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)P-Glycoprotein Inhibitors (Mechanism)
Identifiers: Product ID 70710-1937_9fc482f4-8fb1-47a3-a3ba-55f96fc92287SPL ID 9fc482f4-8fb1-47a3-a3ba-55f96fc92287SPL set ID a9a1a522-231b-41a1-95c6-0c75dbb62f47RxCUI 1665057UNII V3888OEY5RUPC 0370710193775
Pharmacologic class: Calcium Channel Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N470710193707 followed by a unit qualifier and the quantity

Package 70710-1937-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 6, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Verapamil hydrochloride injection, USP is indicated for the following: Rapid conversion to sinus rhythm of paroxysmal supraventricular tachycardias, including those associated with accessory bypass tracts (Wolff-Parkinson-White [W-P-W] and Lown-Ganong-Levine [L-G-L] syndromes). When clinically advisable, appropriate vagal maneuvers (e.g., Valsalva maneuver) should be attempted prior to verapamil hydrochloride administration. Temporary control of rapid ventricular rate in atrial flutter or atrial fibrillation except when the atrial flutter and/or atrial fibrillation are associated with accessory bypass tracts (Wolff-Parkinson-White (W-P-W) and Lown-Ganong-Levine (L-G-L) …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70710-1937

What is NDC 70710-1937?: 70710-1937 is the product NDC for Verapamil Hydrochloride, Verapamil hydrochloride 2.5 mg/mL injection, solution, listed with the FDA by Zydus Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Verapamil Hydrochloride.
What is the active ingredient?: Verapamil hydrochloride.
Who is the labeler?: Zydus Pharmaceuticals USA Inc., NDC labeler code 70710. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Verapamil Hydrochloride?: 131 other product NDCs are listed under this name. See all Verapamil Hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Verapamil Hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Verapamil hydrochloride	Verapamil hydrochloride 120 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1953	70771-1953-0170771-1953-05
Verapamil hydrochloride	Verapamil hydrochloride 180 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1954	70771-1954-0170771-1954-05
Verapamil hydrochloride	Verapamil hydrochloride 240 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1955	70771-1955-0170771-1955-05
Verapamil hydrochloride	Verapamil hydrochloride 120 mg/1	TabletOral	Zydus Pharmaceuticals (USA) Inc.	68382-561	68382-0561-0168382-0561-05
Verapamil hydrochloride	Verapamil hydrochloride 180 mg/1	TabletOral	Zydus Pharmaceuticals (USA) Inc.	68382-562	68382-0562-0168382-0562-05
Verapamil hydrochloride	Verapamil hydrochloride 240 mg/1	TabletOral	Zydus Pharmaceuticals (USA) Inc.	68382-563	68382-0563-0168382-0563-05
Verapamil Hydrochloride	Verapamil hydrochloride 120 mg/1	Capsule, Extended releaseOral	Safecor Health LLC	48433-145	48433-0145-20
Verapamil Hydrochloride	Verapamil hydrochloride 180 mg/1	TabletOral	REMEDYREPACK INC.	70518-4513	70518-4513-00
Verapamil Hydrochloride	Verapamil hydrochloride 2.5 mg/mL	Injection, SolutionIntravenous	REMEDYREPACK INC.	70518-4453	70518-4453-00
Verapamil Hydrochloride	Verapamil hydrochloride 2.5 mg/mL	Injection, SolutionIntravenous	Caplin Steriles Limited	65145-114	65145-0114-05

All 132 Verapamil Hydrochloride NDCs

Other NDCs under ANDA 214215

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214215
Product	Strength	Form · route	Labeler	Product NDC
Verapamil Hydrochloride	Verapamil hydrochloride 2.5 mg/mL	Injection, SolutionIntravenous	Zydus Pharmaceuticals USA Inc.	70710-1643
Verapamil Hydrochloride	Verapamil hydrochloride 2.5 mg/mL	Injection, SolutionIntravenous	Zydus Pharmaceuticals USA Inc.	70710-1644
Verapamil Hydrochloride	Verapamil hydrochloride 2.5 mg/mL	Injection, SolutionIntravenous	Zydus Lifesciences Limited	70771-1601
Verapamil Hydrochloride	Verapamil hydrochloride 2.5 mg/mL	Injection, SolutionIntravenous	Zydus Lifesciences Limited	70771-1602